Globeflex Capital L P Myriad Genetics Inc Transaction History

Globeflex Capital L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $192,024 - $293,994	10,545 New	10,545 $201,000
Q1 2019 May 10, 2019	SELL	$26.93 - $34.7 $735,108 - $947,205	-27,297 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $165,204 - $276,412	6,067 Added 28.58%	27,297 $794,000
Q2 2018 Aug 10, 2018	BUY	$27.75 - $40.17 $155,400 - $224,952	5,600 Added 35.83%	21,230 $793,000
Q1 2018 May 14, 2018	BUY	$28.83 - $41.01 $450,612 - $640,986	15,630 New	15,630 $462,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.